Labcorp Holdings Files 8-K Report

TL;DR

Labcorp filed an 8-K, likely a material agreement or financial update.

AI Summary

On September 23, 2024, LABCORP HOLDINGS INC. filed an 8-K report. The filing indicates the company entered into a material definitive agreement and also includes financial statements and exhibits. No specific details regarding the agreement or financial figures were provided in the excerpt.

Why It Matters

This filing signals a significant event for Labcorp Holdings, potentially involving a new agreement or updated financial information that could impact investors.

Risk Assessment

Risk Level: low — The filing is a standard disclosure and does not contain information suggesting immediate risk.

Key Players & Entities

• LABCORP HOLDINGS INC. (company) — Registrant
• September 23, 2024 (date) — Date of Report
• 358 South Main Street, Burlington, North Carolina 27215 (location) — Principal executive offices
• 336-229-1127 (phone_number) — Registrant's telephone number

FAQ

From the Filing

0001193125-24-223695.txt : 20240923 0001193125-24-223695.hdr.sgml : 20240923 20240923161859 ACCESSION NUMBER: 0001193125-24-223695 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 19 CONFORMED PERIOD OF REPORT: 20240923 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240923 DATE AS OF CHANGE: 20240923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABCORP HOLDINGS INC. CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 992588107 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 241316458 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS DATE OF NAME CHANGE: 19950504 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 d844966d8k.htm 8-K 8-K false 0000920148 0000920148 2024-09-23 2024-09-23     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 2024     LABCORP HOLDINGS INC. (Exact name of registrant as specified in Charter)       Delaware   1-11353   99-2588107 (State or other jurisdiction of incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   358 South Main Street , Burlington , North Carolina   27215 (Address of principal executive offices)   (Zip Code) 336 - 229-1127 Registrant’s telephone number, including area code N/A (Former name or former address, if changed since last report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.10 par value   LH   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 1.01 Entry into a Material Definitive Agreement. On September 23, 2024, Laboratory Corporation of America Holdings (the “Issuer”) entered into a base indenture with U.S. Bank Trust Company, National Association, as trustee (the “Trustee”) (the “Indenture”). On September 23, 2024, Labcorp Holdings Inc. (the “Company”), the Issuer and the Trustee entered into supplemental indentures to the Indenture un